Pepsinogen i and II expressions in situ and their correlations with serum pesignogen levels in gastric cancer and its precancerous disease

BMC Clinical Pathology

Volumn 13, Issue 1, 2013, Pages

  Li, Ping ^a   He, Caiyun ^a   Sun, Liping ^a   Dong, Nannan ^a   Yuan, Yuan ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Correlation; Gastric disease; Pepsinogen

Indexed keywords

IMMUNOGLOBULIN G; PEPSINOGEN I; PEPSINOGEN II;

ADULT; ARTICLE; CORRELATIONAL STUDY; CROSS-SECTIONAL STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HELICOBACTER PYLORI; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PRECANCER; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RETROSPECTIVE STUDY; STOMACH CANCER; STOMACH MUCOSA;

EID: 84883152372     PISSN: None     EISSN: 14726890     Source Type: Journal    
DOI: 10.1186/1472-6890-13-22     Document Type: Article

References (22)

1. Pepsinogens, progastricsins, and prochymosins: structure, function, evolution, and development. Kageyama T, Cell Mol Life Sci 2002 59 2 288 306 10.1007/s00018-002-8423-9 11915945 (Pubitemid 34169515)
2. Evidence for a major dominance component in the variation of serum pepsinogen I levels. Rotter JI, Wong FL, Samloff IM, Varis K, Siurala M, Ihamaki T, Ellis A, McConnell RB, Am J Hum Genet 1982 34 3 395 401 7081219 (Pubitemid 12121374)
3. Correlation of ratio of serum pepsinogen I and II with prevalence of gastric cancer and adenoma in Japanese subjects. Yoshihara M, Sumii K, Haruma K, Kiyohira K, Hattori N, Kitadai Y, Komoto K, Tanaka S, Kajiyama G, Am J Gastroenterol 1998 93 7 1090 1096 10.1111/j.1572-0241.1998.00335.x 9672336 (Pubitemid 29080956)
4. Validity of serum pepsinogen I/II ratio for the diagnosis of gastric epithelial dysplasia and intestinal metaplasia during the follow-up of patients at risk for intestinal-type gastric adenocarcinoma. Dinis-Ribeiro M, da Costa-Pereira A, Lopes C, Barbosa J, Guilherme M, Moreira-Dias L, Lomba-Viana H, Silva R, Abreu N, Lomba-Viana R, Neoplasia New York, NY 2004 6 5 449 456 10.1593/neo.03505 (Pubitemid 39411081)
5. Plasma pepsinogens, antibodies against helicobacter pylori, and risk of gastric cancer in the shanghai Women's health study cohort. Abnet CC, Zheng W, Ye W, Kamangar F, Ji BT, Persson C, Yang G, Li HL, Rothman N, Shu XO, et al. Br J Cancer 2011 104 9 1511 1516 10.1038/bjc.2011.77 21407214
6. The identification for high risk group of gastric cancer using serum pepsinogen after successful eradication of helicobacter pylori. Haneda M, Kato M, Ishigaki S, Suzuki M, Takahashi M, Nakagawa M, Ono S, Mori Y, Mabe K, Nakagawa S, et al. J Gastroenterol Hepatol 2013 28 1 78 83 10.1111/j.1440-1746. 2012.07285.x 23034090
7. The role of serum pepsinogen in the detection of gastric cancer. Kim N, Jung HC, Gut and liver 2010 4 3 307 319 10.5009/gnl.2010.4.3.307 20981206
8. Consensus on chronic gastritis formulated at the national symposium. Lin SB, Yu ZL, Hu PJ, Wang CW, Xu GM, Xiao SD, Shi R, Liu WZ, Zhonghua Xiaohua Zazhi 2000 20 199 201
9. Classification and grading of gastritis. The updated Sydney system. International workshop on the histopathology of Gastritis, Houston 1994. Dixon MF, Genta RM, Yardley JH, Correa P, Am J Surg Pathol 1996 20 10 1161 1181 10.1097/00000478-199610000-00001 8827022 (Pubitemid 26336840)
10. Pathology and genetics of tumors of the digestive system. Hamilton SR, Aaltonen LA, World health organization classification of tumors IARC Press: Lyon, Kleihues P, Sobin LH, 2000 37 50
11. Tissue and serum pepsinogen I and II in gastric cancer identified using immunohistochemistry and rapid ELISA. Konishi N, Matsumoto K, Hiasa Y, Kitahori Y, Hayashi I, Matsuda H, J Clin Pathol 1995 48 4 364 367 10.1136/jcp.48.4.364 7615858
12. Dynamic expression of pepsinogen C in gastric cancer, precancerous lesions and helicobacter pylori associated gastric diseases. Ning PF, Liu HJ, Yuan Y, World J Gastroenterol 2005 11 17 2545 2548 15849808 (Pubitemid 40704267)
13. Comparative study of serology and histology based detection of helicobacter pylori infections: a large population-based study of 7,241 subjects from China. Gong YH, Sun LP, Jin SG, Yuan Y, Eur J Clin Microbiol Infect Dis 2010 29 7 907 911 10.1007/s10096-010-0944-9 20440530
14. Serum pepsinogen levels and their influencing factors: a population-based study in 6990 Chinese from North China. Sun LP, Gong YH, Wang L, Yuan Y, World J Gastroenterol 2007 13 48 6562 6567 10.3748/wjg.13.6562 18161928
15. Serum level of pepsinogen significantly associated with gastric distress induced by amino-bisphosphonates. Shiraki M, Yamazaki Y, Kuroda T, Tanaka S, Miyata K, Osteoporos Int 2011 22 6 1717 1723 10.1007/s00198-010-1374-3 21069296
16. Serum pepsinogen concentration as a marker of Helicobacter pyloriinfection and the histologic grade of gastritis; evaluation of gastric mucosa by serum pepsinogen levels. Kiyohira K, Yoshihara M, Ito M, Haruma K, Tanaka S, Chayama K, J Gastroenterol 2003 38 4 332 338 10.1007/s005350300060 12743772 (Pubitemid 36626268)
17. Human gastric carcinogenesis: a multistep and multifactorial process-first American cancer society award lecture on cancer epidemiology and prevention. Correa P, Cancer Res 1992 52 24 6735 6740 1458460 (Pubitemid 23006271)
18. Helicobacter pylori stimulates pepsinogen secretion from isolated human peptic cells. Lorente S, Doiz O, Trinidad Serrano M, Castillo J, Lanas A, Gut 2002 50 1 13 18 10.1136/gut.50.1.13 11772960 (Pubitemid 34028296)
19. Combination of gastric atrophy, reflux symptoms and histological subtype indicates two distinct aetiologies of gastric cardia cancer. Derakhshan MH, Malekzadeh R, Watabe H, Yazdanbod A, Fyfe V, Kazemi A, Rakhshani N, Didevar R, Sotoudeh M, Zolfeghari AA, et al. Gut 2008 57 3 298 305 10.1136/gut.2007.137364 17965056 (Pubitemid 351288093)
20. Localization of pepsinogen (A and C) and cellular differentiation of pepsinogen-synthesizing cells in the human gastric mucosa. Waalewijn RA, Meuwissen SG, Pals G, Hoefsmit EC, Eur J Cell Biol 1991 54 1 55 60 2032552
21. Pepsinogens I and II in carcinoma of the stomach: an immunohistochemical study. Stemmermann GN, Samloff IM, Hayashi T, Applied pathology 1985 3 3 159 163 3915949 (Pubitemid 17170257)
22. The effects of continuous ambulatory peritoneal dialysis and hemodialysis on serum pepsinogen concentrations in patients with chronic renal failure. Aydemir S, Borazan A, Acikgoz S, Ustundag Y, Yilmaz A, Tohoku J Exp Med 2005 205 3 263 268 10.1620/tjem.205.263 15718818 (Pubitemid 40584894)